KSQ-4279(1), the first ubiquitin-specific protease 1(USP1) inhibitor to enter phase Ⅰ clinical trials, is being evaluated for the treatment of multiple cancers, including ovarian and triple-negative breast cancer. Due to its novel and unique structure, 1has emerged as a key lead compound for the design and scaffold modification of this class of inhibitors. Systematic modifications and structure-activity relationship analyses of the four structural units of 1have revealed the functional characteristics of each fragment. In recent years, structural modifications of 1have yielded numerous“me-too” candidates. This review summarizes the modification strategies and structure-activity relationship studies of 1, aiming to provide valuable insights and references for future research in this field.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |